SCHEMBL820772

SCHEMBL820772

COC(=O)C/C=C/C/C=C/CC(=O)OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.46
CYP4A11 Q02928 2/20 0.46
TSHR P16473 5/20 0.46
HSD17B10 Q99714 2/20 0.42
MGAM O43451 1/20 0.42
GAA P10253 1/20 0.42
SI P14410 1/20 0.42
MGAM2 Q2M2H8 1/20 0.42
OXER1 Q8TDS5 2/20 0.41
CYP2C19 P33261 2/20 0.40
CYP2C9 P11712 1/20 0.40
LMNA P02545 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 3/20 0.37
MAPT P10636 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
ALOX5 P09917 1/20 0.37
CYP3A4 P08684 1/20 0.36
HSP90AB1 P08238 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL821076 0.92 TSHR (0.53) CYP4F2CYP4A11TSHRHSD17B10MGAM
SCHEMBL869082 0.92 TSHR (0.53) CYP4F2CYP4A11TSHRHSD17B10MGAM
SCHEMBL869080 0.92 TSHR (0.53) CYP4F2CYP4A11TSHRHSD17B10MGAM
SCHEMBL16580123 0.91 OXER1 (0.51) CYP4F2CYP4A11TSHRHSD17B10OXER1
SCHEMBL820777 0.91 OXER1 (0.51) CYP4F2CYP4A11TSHRHSD17B10OXER1
SCHEMBL17399524 0.91 TSHR (0.44) CYP4F2CYP4A11TSHRHSD17B10MGAM
SCHEMBL17676486 0.91 OXER1 (0.51) CYP4F2CYP4A11TSHRHSD17B10OXER1
SCHEMBL17720225 0.91 MGAM (0.46) CYP4F2CYP4A11TSHRHSD17B10MGAM
SCHEMBL17720224 0.91 MGAM (0.46) CYP4F2CYP4A11TSHRHSD17B10MGAM
SCHEMBL16093126 0.91 TSHR (0.44) CYP4F2CYP4A11TSHRHSD17B10MGAM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067623-B2 Producing waxes from soybean oil; ruthenium alkylidene catalytic, simultaneous opening and inserting ELEVANCE RENEWABLE SCIENCES, INC. (US) 2011-11-29 US disclosed
US-20080064891-A1 Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like WILMAR TRADING PTE LTD (SG) 2008-03-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080064891-A1 Ring opening cross-metathesis reaction of cyclic olefins with seed oils and the like SQLE, COASY, ALOX12 CYP4F2 586/4885CYP4A11 468/4885TSHR 4692/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.